{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T00:51:54Z","timestamp":1745542314471,"version":"3.37.3"},"reference-count":47,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,8]],"date-time":"2024-02-08T00:00:00Z","timestamp":1707350400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cientifico e Tecnologico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Hepatology"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.aohep.2024.101477","type":"journal-article","created":{"date-parts":[[2024,2,14]],"date-time":"2024-02-14T13:36:10Z","timestamp":1707917770000},"page":"101477","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Psoriasis and steatotic liver disease: Are PNPLA3 and TM6SF2 polymorphisms suitable for the hepato-dermal axis hypothesis?"],"prefix":"10.1016","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2284-4111","authenticated-orcid":false,"given":"Luciana","family":"Agoglia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Carolina","family":"Cardoso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L\u00edvia","family":"Barbosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cec\u00edlia Schubert Xavier Lagalhard","family":"Victer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7515-2365","authenticated-orcid":false,"given":"Sueli","family":"Carneiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paulo Henrique Condeixa","family":"de Fran\u00e7a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5817-9221","authenticated-orcid":false,"given":"Maria Chiara","family":"Chindamo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1355-2368","authenticated-orcid":false,"given":"Cristiane Alves","family":"Villela-Nogueira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl 2","key":"10.1016\/j.aohep.2024.101477_bib0001","first-page":"ii30","article-title":"Psoriasis pathophysiology: current concepts of pathogenesis","volume":"64","author":"Krueger","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.aohep.2024.101477_bib0002","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/jid.2012.339","article-title":"Global epidemiology of psoriasis: a systematic review of incidence and prevalence","volume":"133","author":"Parisi","year":"2013","journal-title":"J Investig Dermatol"},{"issue":"4","key":"10.1016\/j.aohep.2024.101477_bib0003","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1097\/BOR.0b013e3283031c99","article-title":"Psoriasis and metabolic disease: epidemiology and pathophysiology","volume":"20","author":"Azfar","year":"2008","journal-title":"Curr Opin Rheumatol"},{"issue":"1","key":"10.1016\/j.aohep.2024.101477_bib0004","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.clindermatol.2017.09.005","article-title":"Psoriasis and the metabolic syndrome","volume":"36","author":"Gisondi","year":"2018","journal-title":"Clin Dermatol"},{"issue":"4","key":"10.1016\/j.aohep.2024.101477_bib0005","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1111\/jdv.12847","article-title":"Risk of non-alcoholic fatty liver disease in patients with psoriasis: a systematic review and meta-analysis","volume":"29","author":"Candia","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"6","key":"10.1016\/j.aohep.2024.101477_bib0006","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.jhep.2015.11.004","article-title":"Clinical practice guidelines for the management of non-alcoholic fatty liver disease","volume":"64","year":"2016","journal-title":"J Hepatol"},{"issue":"5","key":"10.1016\/j.aohep.2024.101477_bib0007","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1097\/HEP.0000000000000323","article-title":"AASLD practice guidance on the clinical assessment and management of nonalcoholic fatty liver disease","volume":"77","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"issue":"03","key":"10.1016\/j.aohep.2024.101477_bib0008","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1055\/s-0035-1562944","article-title":"Systemic complications of nonalcoholic fatty liver disease: when the liver is not an innocent bystander","volume":"35","author":"Vanni","year":"2015","journal-title":"Semin Liver Dis"},{"issue":"4","key":"10.1016\/j.aohep.2024.101477_bib0009","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.jhep.2009.04.020","article-title":"Non-alcoholic fatty liver disease in patients with chronic plaque psoriasis","volume":"51","author":"Gisondi","year":"2009","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.aohep.2024.101477_bib0010","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.jaad.2013.10.044","article-title":"Psoriasis is independently associated with nonalcoholic fatty liver disease in patients 55 years old or older: results from a population-based study","volume":"70","author":"van der Voort","year":"2014","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.aohep.2024.101477_bib0011","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1046\/j.1365-2036.2004.01819.x","article-title":"Monitoring methotrexate-induced hepatic fibrosis in patients with psoriasis: are serial liver biopsies justified?: Monitoring methotrexate-induced fibrosis","volume":"19","author":"Aithal","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.aohep.2024.101477_bib0012","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1111\/j.1365-2036.2006.03047.x","article-title":"Liver injury in long-term methotrexate treatment in psoriasis is relatively infrequent","volume":"24","author":"Berends","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.aohep.2024.101477_bib0013","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.jhep.2007.01.024","article-title":"Psoriasis patients with diabetes type 2 are at high risk of developing liver fibrosis during methotrexate treatment","volume":"46","author":"Rosenberg","year":"2007","journal-title":"J Hepatol"},{"issue":"5","key":"10.1016\/j.aohep.2024.101477_bib0014","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1093\/rheumatology\/kep023","article-title":"Liver fibrosis in patients with psoriasis and psoriatic arthritis on long-term, high cumulative dose methotrexate therapy","volume":"48","author":"Lindsay","year":"2008","journal-title":"Rheumatology"},{"issue":"5","key":"10.1016\/j.aohep.2024.101477_bib0015","doi-asserted-by":"crossref","first-page":"275","DOI":"10.4254\/wjh.v5.i5.275","article-title":"Prevalence and risk factors of methotrexate hepatoxicity in asian patients with psoriasis","volume":"5","author":"Yeo","year":"2013","journal-title":"World J Hepatol"},{"key":"10.1016\/j.aohep.2024.101477_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2022.12.034","article-title":"Risk of liver fibrosis associated with long-term methotrexate therapy may be overestimated","author":"Atallah","year":"2023","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.aohep.2024.101477_bib0017","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3390\/ijms17020217","article-title":"Relationship between non-alcoholic fatty liver disease and psoriasis: a novel hepato-dermal axis?","volume":"17","author":"Mantovani","year":"2016","journal-title":"IJMS"},{"issue":"12","key":"10.1016\/j.aohep.2024.101477_bib0018","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1038\/ng.257","article-title":"Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease","volume":"40","author":"Romeo","year":"2008","journal-title":"Nat Genet"},{"issue":"2","key":"10.1016\/j.aohep.2024.101477_bib0019","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.jhep.2016.03.011","article-title":"PNPLA3 gene in liver diseases","volume":"65","author":"Tr\u00e9po","year":"2016","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.aohep.2024.101477_bib0020","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/ng.2901","article-title":"Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease","volume":"46","author":"Kozlitina","year":"2014","journal-title":"Nat Genet"},{"issue":"1","key":"10.1016\/j.aohep.2024.101477_bib0021","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1741-7015-9-48","article-title":"Metabolic syndrome: definitions and controversies","volume":"9","author":"Kassi","year":"2011","journal-title":"BMC Med"},{"issue":"6","key":"10.1016\/j.aohep.2024.101477_bib0022","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0399-8320(08)73994-0","article-title":"Transient elastography (FibroScan)","volume":"32","author":"de L\u00e9dinghen","year":"2008","journal-title":"Gastroent\u00e9rol Clin Biol"},{"issue":"11","key":"10.1016\/j.aohep.2024.101477_bib0023","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1136\/gutjnl-2018-317334","article-title":"Unified interpretation of liver stiffness measurement by M and XL probes in non-alcoholic fatty liver disease","volume":"68","author":"Wong","year":"2019","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.aohep.2024.101477_bib0024","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.jhep.2021.05.025","article-title":"EASL clinical practice guidelines on non-invasive tests for evaluation of liver disease severity and prognosis \u20132021 update","volume":"75","author":"Berzigotti","year":"2021","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.aohep.2024.101477_bib0025","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/hep.27556","article-title":"Genetic variation in transmembrane 6 superfamily member 2 and the risk of nonalcoholic fatty liver disease and histological disease severity","volume":"61","author":"Sookoian","year":"2015","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.aohep.2024.101477_bib0026","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.aohep.2018.10.004","article-title":"Validation of PNPLA3 polymorphisms as risk factor for NAFLD and liver fibrosis in an admixed population","volume":"18","author":"Mazo","year":"2019","journal-title":"Ann Hepatol"},{"issue":"9","key":"10.1016\/j.aohep.2024.101477_bib0027","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.numecd.2019.06.002","article-title":"PNPLA3 gene polymorphism in brazilian patients with type 2 diabetes: a prognostic marker beyond liver disease?","volume":"29","author":"Machado","year":"2019","journal-title":"Nutr Metabol Cardiovasc Dis"},{"issue":"04","key":"10.1016\/j.aohep.2024.101477_bib0028","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1055\/s-0041-1730927","article-title":"Insights into nonalcoholic fatty-liver disease heterogeneity","volume":"41","author":"Arrese","year":"2021","journal-title":"Semin Liver Dis"},{"issue":"22","key":"10.1016\/j.aohep.2024.101477_bib0029","doi-asserted-by":"crossref","first-page":"6892","DOI":"10.3748\/wjg.v21.i22.6892","article-title":"Nonalcoholic fatty liver disease, spleen and psoriasis: new aspects of low-grade chronic inflammation","volume":"21","author":"Balato","year":"2015","journal-title":"World J Gastroenterol"},{"issue":"6","key":"10.1016\/j.aohep.2024.101477_bib0030","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1002\/hep.24283","article-title":"Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease","volume":"53","author":"Sookoian","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.aohep.2024.101477_bib0031","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/7963972","article-title":"Liver stiffness measurement in psoriasis: do metabolic or disease factors play the important role?","volume":"2016","author":"Pongpit","year":"2016","journal-title":"Biomed Res Int"},{"issue":"9","key":"10.1016\/j.aohep.2024.101477_bib0032","doi-asserted-by":"crossref","first-page":"6706","DOI":"10.1074\/jbc.M109.064501","article-title":"Sequence variation (I148M) in PNPLA3 associated with nonalcoholic fatty liver disease disrupts triglyceride hydrolysis","volume":"285","author":"He","year":"2010","journal-title":"J Biol Chem"},{"issue":"5","key":"10.1016\/j.aohep.2024.101477_bib0033","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1002\/hep.32510","article-title":"Should PNPLA3 polymorphism be performed in clinical practice in patients with NAFLD to predict the risk of disease progression?","volume":"76","author":"Oliveira","year":"2022","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.aohep.2024.101477_bib0034","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1002\/hep.32491","article-title":"PNPLA3 Rs738409 and risk of fibrosis in NAFLD: exploring mediation pathways through intermediate histological features","volume":"76","author":"Vilar-Gomez","year":"2022","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.aohep.2024.101477_bib0035","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1002\/hep.27490","article-title":"Transmembrane 6 superfamily member 2 gene variant disentangles nonalcoholic steatohepatitis from cardiovascular disease","volume":"61","author":"Dongiovanni","year":"2015","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.aohep.2024.101477_bib0036","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/j.jhep.2020.02.020","article-title":"Update on NAFLD genetics: from new variants to the clinic","volume":"72","author":"Tr\u00e9po","year":"2020","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.aohep.2024.101477_bib0037","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/bjd.16239","article-title":"Nonalcoholic fatty liver disease in patients with psoriasis: a consequence of systemic inflammatory burden?","volume":"179","author":"Prussick","year":"2018","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.aohep.2024.101477_bib0038","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/s41584-022-00883-4","article-title":"Busting the myth of methotrexate chronic hepatotoxicity","volume":"19","author":"Di Martino","year":"2023","journal-title":"Nat Rev Rheumatol"},{"issue":"6","key":"10.1016\/j.aohep.2024.101477_bib0039","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.jhep.2010.04.043","article-title":"Assessment of liver fibrosis with transient elastography and fibrotest in patients treated with methotrexate for chronic inflammatory diseases: a case-control study","volume":"53","author":"Laharie","year":"2010","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.aohep.2024.101477_bib0040","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2340\/00015555-2161","article-title":"Increased prevalence of advanced liver fibrosis in patients with psoriasis: a cross-sectional analysis from the rotterdam study","volume":"96","author":"Voort","year":"2016","journal-title":"Acta Derm Venerol"},{"issue":"5","key":"10.1016\/j.aohep.2024.101477_bib0041","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s00403-017-1733-4","article-title":"Diagnostic performance of transient elastography for detection of methotrexate-induced liver injury using roenigk classification in asian patients with psoriasis: a retrospective study","volume":"309","author":"Rongngern","year":"2017","journal-title":"Arch Dermatol Res"},{"issue":"9","key":"10.1016\/j.aohep.2024.101477_bib0042","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1001\/jamadermatol.2019.0721","article-title":"Prevalence of advanced liver fibrosis in patients with severe psoriasis","volume":"155","author":"Maybury","year":"2019","journal-title":"JAMA Dermatol"},{"issue":"5","key":"10.1016\/j.aohep.2024.101477_bib0043","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.jhep.2023.02.018","article-title":"Methotrexate-induced liver fibrosis: the end of a long-held belief","volume":"78","author":"Martino","year":"2023","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.aohep.2024.101477_bib0044","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/bjd.12941","article-title":"Methotrexate and liver fibrosis in people with psoriasis: a systematic review of observational studies","volume":"171","author":"Maybury","year":"2014","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.aohep.2024.101477_bib0045","doi-asserted-by":"crossref","first-page":"2998","DOI":"10.1002\/hep.32063","article-title":"Modeling PNPLA3-associated NAFLD using human-induced pluripotent stem cells","volume":"74","author":"Tilson","year":"2021","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.aohep.2024.101477_bib0046","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1002\/hep.23312","article-title":"de L\u00e9dinghen, V. Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease","volume":"51","author":"Wong","year":"2010","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.aohep.2024.101477_bib0047","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.jhep.2016.12.022","article-title":"Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis","volume":"66","author":"Karlas","year":"2017","journal-title":"J Hepatol"}],"container-title":["Annals of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268124002710?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268124002710?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T23:45:14Z","timestamp":1719531914000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1665268124002710"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":47,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S1665268124002710"],"URL":"https:\/\/doi.org\/10.1016\/j.aohep.2024.101477","relation":{},"ISSN":["1665-2681"],"issn-type":[{"type":"print","value":"1665-2681"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Psoriasis and steatotic liver disease: Are PNPLA3 and TM6SF2 polymorphisms suitable for the hepato-dermal axis hypothesis?","name":"articletitle","label":"Article Title"},{"value":"Annals of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aohep.2024.101477","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Fundaci\u00f3n Cl\u00ednica M\u00e9dica Sur, A.C. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"101477"}}